KEGG   DRUG: Nirsevimab
Entry
D11380                      Drug                                   
Name
Nirsevimab (USAN);
Nirsevimab (genetical recombination) (JAN);
Nirsevimab-alip;
Beyfortus (TN)
Product
Formula
C6494H10060N1708O2050S46
Exact mass
146244.2605
Mol weight
146334.5658
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGSSVMV SCQASGGLLE DYIINWVRQA PGQGPEWMGG IIPVLGTVHY
GPKFQGRVTI TADESTDTAY MELSSLRSED TAMYYCATET ALVVSETYLP HYFDNWGQGT
LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA
PELLGGPSVF LFPPKPKDTL YITREPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP
REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL
PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT
VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
(Light chain)
DIQMTQSPSS LSAAVGDRVT ITCQASQDIV NYLNWYQQKP GKAPKLLIYV ASNLETGVPS
RFSGSGSGTD FSLTISSLQP EDVATYYCQQ YDNLPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H153-H209, H229-L214, H235-H'235, H238-H'238, H270-H330, H376-H434, H'22-H'96, H'153-H'209, H'229-L'214, H'270-H'330, H'376-H'434, L23-L88, L'23-L'88, L134-L194, L'134-L'194)
  Type
Peptide
Remark
Therapeutic category: 6250
ATC code: J06BD08
Product: D11380<JP/US>
Efficacy
Antiviral
  Disease
RSV disease [DS:H00401]
  Type
Monoclonal antibody
Comment
Prevention of respiratory syncytial virus infection
Target
RSV F protein [KO:K19261]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BD Antiviral monoclonal antibodies
     J06BD08 Nirsevimab
      D11380  Nirsevimab (USAN) <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Respiratory Tract Agents, Other
   Immunomodulators
    Nirsevimab
     D11380  Nirsevimab (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11380  Nirsevimab (USAN); Nirsevimab (genetical recombination) (JAN)
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   RSV F protein
    D11380  Nirsevimab (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11380
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11380
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11380
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11380
Other DBs
CAS: 1989556-22-0
PubChem: 384585358
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system